At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...

No longer will our medicines be gated through animals, but rather through entirely human systems — leading to breakthrough ...

Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the incorporation of Pathway Maps in OFF-X, a cutting-edge translational safety intelligence ...

Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

Adapting to uncertainty over product review timelines at FDA could complicate M&A for pharma buyers and sellers, especially ...

Driven by a commitment to achieve excellence since 1955, the Thomas J. Long School of Pharmacy trains pharmacists to excel as ...

By combining information from many large datasets, MIT researchers have identified several new potential targets for treating or preventing Alzheimer's disease.

Using a computational strategy that allows them to combine information from many large datasets, MIT researchers have identified several new potential targets for Alzheimer’s disease.

A new study published in Aging Cell demonstrates that artificial intelligence can be used not just to accelerate drug ...

The focus of this review is on the development of small molecule tyrosine kinase inhibitors, and does not extend to other approaches that could be applied to disrupt the same pathways in clinical ...

When Covid-19 emerged, it became clear that conventional approaches to health care and drug development wouldn ... and creating bespoke pathways for promising candidates. This allowed industry ...

Successful drug development for bioactive lipid targets requires a deep knowledge of the biology and pathobiology of each specific lipid signaling pathway. Successful development of drugs for ...